Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial — Professor Gregory Lip (2024) | RDL Network
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial
Hans‐Christoph Diener, Nina Becher, Susanne Sehner, Tobias Toennis, Emanuele Bertaglia, Carina Blomström‐Lundqvist, Axel Brandes, Vincent Beuger, Melanie Calvert, A. John Camm, Gregory Chlouverakis, Gheorghe‐Andrei Dan, Wolfgang Dichtl, Alexander Fierenz, Andreas Goette, Joris R. de Groot, Astrid N L Hermans, Professor Gregory Lip, Andrzej Lubiński, Éloi Marijon, Béla Merkely, Lluı́s Mont, Julius Nikorowitsch, Ann‐Kathrin Ozga, Kim Rajappan, Andrea Sarkozy, Douglas S. Scherr, Renate B. Schnabel, Ulrich Schotten, Εmmanuel Simantirakis, Panos Vardas, Dan Wichterle, Antonia Zapf, Paulus Kirchhof
Emma Svennberg, José Luís Merino, Jason G. Andrade, Matteo Anselmino, Elena Arbelo, Eric Boersma, Giuseppe Boriani, Günter Breithardt, Mina K. Chung, Janice Y. Chyou, Ariel Cohen, Jan M. Nielsen, Wolfgang Dichtl, Søren Zöga Diederichsen, Dobromir Dobrev, Wolfram Doehner, Elke Dworatzek, Larissa Fabritz, David Filgueiras‐Rama, Claudio Gimpelewicz, Guido Hack, Stéphane Hatem, ,
Discussion(0)
No comments yet. Be the first to comment.